Influence of preoperative anti-cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: Project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery

Fuyuhiko Motoi, Michiaki Unno, Hidenori Takahashi, Takaho Okada, Keita Wada, Masayuki Sho, Hiroaki Nagano, Ippei Matsumoto, Sohei Satoi, Yoshiaki Murakami, Masashi Kishiwada, Goro Honda, Hisafumi Kinoshita, Hideo Baba, Shoichi Hishinuma, Minoru Kitago, Hidehiro Tajima, Hiroyuki Shinchi, Hiroshi Takamori, Tomoo KosugeHiroki Yamaue, Tadahiro Takada

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background Little is known about the effects of neoadjuvant therapy on outcomes in patients with pancreatic cancer. This study evaluated the effects of neoadjuvant therapy on resectability and perioperative outcomes. Methods A total of 992 patients were enrolled, with 971 deemed eligible. Of these, 582 had resectable tumors and 389 had borderline resectable tumors, and 388 patients received neoadjuvant therapy. Demographic characteristics and peri- and postoperative parameters were assessed by a questionnaire survey. Results The R0 rate was significantly higher in patients with resectable tumors who received neoadjuvant therapy than in those who underwent surgery first, but no significant difference was noted in patients with borderline resectable tumors. Operation time was significantly longer and blood loss was significantly greater in patients who received neoadjuvant therapy than in those who underwent surgery first, but there were no significant differences in specific complications and mortality rates. The node positivity rate was significantly lower in the neoadjuvant than in the surgery-first group, indicating that the former had significantly lower stage tumors. Conclusions Neoadjuvant therapy may not increase the mortality and morbidity rate and may be able to increase the chance for curative resection against resectable tumor.

Original languageEnglish
Pages (from-to)148-158
Number of pages11
JournalJournal of Hepato-Biliary-Pancreatic Sciences
Volume21
Issue number2
DOIs
Publication statusPublished - 2014 Feb

Keywords

  • Neoadjuvant
  • Pancreatic cancer
  • Perioperative outcome
  • Resectability
  • Surgery

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Influence of preoperative anti-cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: Project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery'. Together they form a unique fingerprint.

  • Cite this

    Motoi, F., Unno, M., Takahashi, H., Okada, T., Wada, K., Sho, M., Nagano, H., Matsumoto, I., Satoi, S., Murakami, Y., Kishiwada, M., Honda, G., Kinoshita, H., Baba, H., Hishinuma, S., Kitago, M., Tajima, H., Shinchi, H., Takamori, H., ... Takada, T. (2014). Influence of preoperative anti-cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: Project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. Journal of Hepato-Biliary-Pancreatic Sciences, 21(2), 148-158. https://doi.org/10.1002/jhbp.15